Cardio Diagnostics Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cardio Diagnostics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2021 to Q3 2024.
  • Cardio Diagnostics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.41M, a 2.44% increase year-over-year.
  • Cardio Diagnostics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.39M, a 3.8% decline year-over-year.
  • Cardio Diagnostics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$7.24M, a 59.2% decline from 2022.
  • Cardio Diagnostics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$4.55M, a 633% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$1.41M +$35.2K +2.44% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$1.28M +$1.27M +49.8% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$4.16M -$2.45M -144% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1.54M +$842K +35.3% Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$1.44M -$293K -25.5% Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$2.55M -$1.77M -224% Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$1.7M -$1.48M -650% Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$2.38M Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$1.15M -$1.15M Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$787K -$787K Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$227K Mar 31, 2022 10-Q 2022-05-12
Q3 2021 -$721* Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$397* Jun 30, 2021 10-Q 2022-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.